SSTR2 (Somatostatin Receptor 2)

A key G protein-coupled receptor mediating somatostatin signaling in neuroendocrine regulation and oncology.

Gene Information Card

Symbol SSTR2
Full Name Somatostatin Receptor 2
Gene Type protein-coding
Chromosomal Location 17q25.1
NCBI Gene ID 6752 ncbi.nlm.nih.gov/gene/6752
Ensembl ID ENSG00000180616
UniProt ID P30874
OMIM ID 182452
HGNC ID 11332
Aliases SS2R, SRIF-1

Description

SSTR2 encodes somatostatin receptor 2, a G protein-coupled receptor for somatostatin-14 and -28. It mediates inhibition of hormone secretion, cell proliferation, and induces apoptosis. SSTR2 is highly expressed in neuroendocrine tissues and is a primary target for diagnostic imaging and peptide receptor radionuclide therapy (PRRT) in neuroendocrine tumors.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Neuroendocrine tumors (NETs) SSTR2 overexpression enables targeted imaging and therapy via somatostatin analogs PMID: 31383879
Acromegaly SSTR2 mediates somatostatin-induced suppression of GH secretion; loss of SSTR2 correlates with resistance to somatostatin analogs PMID: 25636053
Gastroenteropancreatic NETs SSTR2 expression is a predictive biomarker for response to octreotide and lanreotide PMID: 28854169

Expression Profile

Tissue Expression
Tissue nTPM level
Pancreas 12.3 Medium
Pituitary 8.7 Medium
Brain (cortex) 6.1 Low
Stomach 15.2 High
Small intestine 18.9 High
Colon 4.5 Low
Cell Line Expression
Cell Line nTPM Notes
BON-1 (pancreatic NET) 22.1 High SSTR2 expression
QGP-1 (pancreatic NET) 18.7 High SSTR2 expression
NCI-H727 (lung carcinoid) 14.3 Moderate SSTR2 expression
HEK293 0.8 Very low endogenous expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.784G>A (p.Gly262Ser) Missense <0.1% Reduced ligand binding affinity
c.1019C>T (p.Thr340Met) Missense <0.1% Impaired receptor internalization
c.1123_1125del (p.Phe375del) In-frame deletion <0.1% Loss of G protein coupling
Mutation functional classification

Loss of Function (LOF)

Mutations such as p.Phe375del impair G protein coupling and signal transduction, reducing somatostatin-mediated inhibition.

Gain of Function (GOF)

No confirmed gain-of-function mutations reported in SSTR2.

Dominant Negative (DN)

No dominant-negative mutations described for SSTR2.

Gene Ontology (GO)

G protein-coupled receptor activity (GO:0004930) somatostatin receptor activity (GO:0004994)
• adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193) negative regulation of cell population proliferation (GO:0008285)
apoptotic process (GO:0006915)

Pathways

Somatostatin signaling (Reactome: R-HSA-418594)
GPCR downstream signaling (Reactome: R-HSA-388396)
Peptide ligand-binding receptors (Reactome: R-HSA-375276)

Protein Summary

Somatostatin receptor 2 (SSTR2) is a 369-amino acid transmembrane GPCR that preferentially binds somatostatin-14 and -28. Upon activation, it couples to Gi/o proteins to inhibit adenylyl cyclase, reduce cAMP, and modulate ion channels. SSTR2 is a key mediator of somatostatin's anti-secretory and anti-proliferative effects, and its overexpression in neuroendocrine tumors is exploited clinically for imaging (68Ga-DOTATATE PET) and therapy (177Lu-DOTATATE PRRT).

Related Products

Product name Cat.No. Species Gene ID
SSTR2 Knockout HEK293 Cell Line EDJ-KQ1791 Human 6752 Details Get a Quote
SSTR2 Knockout HeLa Cell Line EDJ-KQ54571 Human 6752 Details Get a Quote
SSTR2 Knockout A-549 Cell Line EDJ-KQ63056 Human 6752 Details Get a Quote
SSTR2 Knockout HCT 116 Cell Line EDJ-KQ71530 Human 6752 Details Get a Quote
Displaying Records 1 To 4 Of 4 Records
Contact Us
*
*
*
*
How did you hear about us: